n-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulfasalazine in the treatment of inflammatory bowel disease
Clicks: 146
ID: 256244
2007
AIM: N-acetyltransferase 2 (NAT2) is an important enzyme catalyzing N-acetylation of sulfasalazine (SASP). The aim of the present study was to investigate associations of the genotypes of NAT2 with inflammatory bowel disease (IBD), and with adverse effects of SASP, which is used as the first-line treatment of IBD.
| Reference Key |
chen2007canadiann-acetyltransferase
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Min Chen;Bing Xia;Bixiao Chen;Qiusha Guo;Jin Li;Mei Ye;Zhengguo Hu |
| Journal | indian journal of pharmacology |
| Year | 2007 |
| DOI | 10.1155/2007/976804 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.